190 related articles for article (PubMed ID: 8103214)
1. Drug treatment of panic disorder.
Rosenberg R
Pharmacol Toxicol; 1993 Jun; 72(6):344-53. PubMed ID: 8103214
[TBL] [Abstract][Full Text] [Related]
2. Panic disorder: long-term pharmacotherapy and discontinuation.
Rickels K; Schweizer E
J Clin Psychopharmacol; 1998 Dec; 18(6 Suppl 2):12S-18S. PubMed ID: 9872708
[TBL] [Abstract][Full Text] [Related]
3. A 15-year follow-up study of patients with panic disorder.
Andersch S; Hetta J
Eur Psychiatry; 2003 Dec; 18(8):401-8. PubMed ID: 14680716
[TBL] [Abstract][Full Text] [Related]
4. Treatment of panic disorder in older adults: a pilot study comparison of alprazolam, imipramine, and placebo.
Sheikh JI; Swales PJ
Int J Psychiatry Med; 1999; 29(1):107-17. PubMed ID: 10376237
[TBL] [Abstract][Full Text] [Related]
5. The efficacy and safety of alprazolam versus other benzodiazepines in the treatment of panic disorder.
Moylan S; Staples J; Ward SA; Rogerson J; Stein DJ; Berk M
J Clin Psychopharmacol; 2011 Oct; 31(5):647-52. PubMed ID: 21869686
[TBL] [Abstract][Full Text] [Related]
6. Adverse effects associated with the short-term treatment of panic disorder with imipramine, alprazolam or placebo.
Cassano GB; Toni C; Petracca A; Deltito J; Benkert O; Curtis G; Hippius H; Maier W; Shera D; Klerman G
Eur Neuropsychopharmacol; 1994 Mar; 4(1):47-53. PubMed ID: 8204996
[TBL] [Abstract][Full Text] [Related]
7. Influence of depression on the treatment of panic disorder with imipramine, alprazolam and placebo.
Keller MB; Lavori PW; Goldenberg IM; Baker LA; Pollack MH; Sachs GS; Rosenbaum JF; Deltito JA; Leon A; Shear K
J Affect Disord; 1993 May; 28(1):27-38. PubMed ID: 8326078
[TBL] [Abstract][Full Text] [Related]
8. Avoidance behaviour: a predictor of the efficacy of pharmacotherapy in panic disorder?
Maier W; Roth SM; Argyle N; Buller R; Lavori P; Brandon S; Benkert O
Eur Arch Psychiatry Clin Neurosci; 1991; 241(3):151-8. PubMed ID: 1790160
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of alprazolam, imipramine and placebo in treating panic disorder. A Scandinavian multicenter study.
Andersch S; Rosenberg NK; Kullingsjö H; Ottosson JO; Bech P; Bruun-Hansen J; Hanson L; Lorentzen K; Mellergård M; Rasmussen S
Acta Psychiatr Scand Suppl; 1991; 365():18-27. PubMed ID: 1862730
[TBL] [Abstract][Full Text] [Related]
10. Drug treatment of panic disorder. Comparative efficacy of alprazolam, imipramine, and placebo. Cross-National Collaborative Panic Study, Second Phase Investigators.
Br J Psychiatry; 1992 Feb; 160():191-202; discussion 202-5. PubMed ID: 1540759
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of benzodiazepines in panic disorder and agoraphobia.
Ballenger JC
J Psychiatr Res; 1990; 24 Suppl 2():15-25. PubMed ID: 1980694
[TBL] [Abstract][Full Text] [Related]
12. Drug treatment of panic disorder: the comparative efficacy of imipramine, alprazolam, and trazodone.
Charney DS; Woods SW; Goodman WK; Rifkin B; Kinch M; Aiken B; Quadrino LM; Heninger GR
J Clin Psychiatry; 1986 Dec; 47(12):580-6. PubMed ID: 3536889
[TBL] [Abstract][Full Text] [Related]
13. Long-term drug treatment of panic disorder.
Burrows GD; Judd FK; Norman TR
J Psychiatr Res; 1993; 27 Suppl 1():111-25. PubMed ID: 7908330
[TBL] [Abstract][Full Text] [Related]
14. Controlled trial of alprazolam supplementation during imipramine treatment of panic disorder.
Woods SW; Nagy LM; Koleszar AS; Krystal JH; Heninger GR; Charney DS
J Clin Psychopharmacol; 1992 Feb; 12(1):32-8. PubMed ID: 1552038
[TBL] [Abstract][Full Text] [Related]
15. Clinical pharmacology, clinical efficacy, and behavioral toxicity of alprazolam: a review of the literature.
Verster JC; Volkerts ER
CNS Drug Rev; 2004; 10(1):45-76. PubMed ID: 14978513
[TBL] [Abstract][Full Text] [Related]
16. [The efficacy of alprazolam in the therapy of panic disorders].
Diukova GM; Vorob'eva OV; Petrova EP; Smirnov SV; Tumalaeva ZN
Zh Nevrol Psikhiatr Im S S Korsakova; 1995; 95(4):9-13. PubMed ID: 8533521
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the safety and efficacy of alprazolam versus other agents in the treatment of anxiety, panic, and depression: a review of the literature.
Jonas JM; Cohon MS
J Clin Psychiatry; 1993 Oct; 54 Suppl():25-45; discussion 46-8. PubMed ID: 8262888
[TBL] [Abstract][Full Text] [Related]
18. A naturalistic 6-year follow-up study of patients with panic disorder.
Lepola U; Koponen H; Leinonen E
Acta Psychiatr Scand; 1996 Mar; 93(3):181-3. PubMed ID: 8739663
[TBL] [Abstract][Full Text] [Related]
19. Pharmacotherapy of panic disorder: differential efficacy from a clinical viewpoint.
den Boer JA
J Clin Psychiatry; 1998; 59 Suppl 8():30-6; discussion 37-8. PubMed ID: 9707160
[TBL] [Abstract][Full Text] [Related]
20. A meta-analysis of treatments for panic disorder with agoraphobia: imipramine, alprazolam, and in vivo exposure.
Cox BJ; Endler NS; Lee PS; Swinson RP
J Behav Ther Exp Psychiatry; 1992 Sep; 23(3):175-82. PubMed ID: 1487535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
